Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136.5 EUR | +0.19% | -1.90% | -3.56% |
06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- News Johnson & Johnson
- Press Releases